Data I/O (DAIO) Registration filing summary
Event summary combining transcript, slides, and related documents.
Registration filing summary
11 Aug, 2026Offering details and pricing
Registration covers up to 4,686,371 shares of common stock, including 869,840 outstanding shares, 1,080,000 shares issuable upon exercise of warrants, and 2,736,531 shares issuable upon conversion of Series B Convertible Preferred Stock.
Shares are being offered by selling stockholders, with the underlying securities previously issued in a private placement.
The Series B Convertible Preferred Stock was issued upon conversion of convertible debentures dated June 17, 2026.
Risk factors and disclosures
Legal opinion confirms all shares, including those issuable upon exercise or conversion, are validly issued, fully paid, and non-assessable under Washington law.
Management team and governance
Key executives include the President/CEO, Vice President/CFO, and several directors, all of whom have signed the registration statement.
Executive employment agreements and transition agreements with senior management are referenced among the exhibits.
Latest events from Data I/O
- Q2 2026 revenue jumped 59% sequentially, with margin gains, cash boost, and no debt.DAIO
Q2 2026 - Shares from a private placement are registered for resale, with no proceeds to the company.DAIO
Registration filing - Transformation to a service-driven model and major acquisition expand market reach and efficiency.DAIO
Planet MicroCap Las Vegas 2026 - Proxy covers director elections, incentive plan expansion, private placement, and executive pay vote.DAIO
Proxy filing - Proxy covers director elections, auditor ratification, equity plan changes, and major share issuance.DAIO
Proxy filing - $23M acquisition and $9M investment to nearly double revenue and drive growth in 2026.DAIO
Q1 2026 & M&A Announcement - Transformation and AI-driven efficiencies set the stage for growth and margin recovery in 2026.DAIO
Q4 2025 - Revenue up 19% sequentially, losses narrowed, strong liquidity, but trade headwinds persist.DAIO
Q1 2025 - 2024 saw revenue and margin declines, but cost cuts and backlog support 2025 recovery.DAIO
Q4 2024